These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 22484818)
1. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. Anderson PD; McKissic SA; Logan M; Roh M; Franco OE; Wang J; Doubinskaia I; van der Meer R; Hayward SW; Eischen CM; Eltoum IE; Abdulkadir SA J Clin Invest; 2012 May; 122(5):1907-19. PubMed ID: 22484818 [TBL] [Abstract][Full Text] [Related]
2. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells. Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545 [TBL] [Abstract][Full Text] [Related]
3. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465 [TBL] [Abstract][Full Text] [Related]
4. Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN. Sharma P; Knowell AE; Chinaranagari S; Komaragiri S; Nagappan P; Patel D; Havrda MC; Chaudhary J Mol Cancer; 2013 Jun; 12():67. PubMed ID: 23786676 [TBL] [Abstract][Full Text] [Related]
5. Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice. Kladney RD; Cardiff RD; Kwiatkowski DJ; Chiang GG; Weber JD; Arbeit JM; Lu ZH Cancer Res; 2010 Nov; 70(21):8937-47. PubMed ID: 20940396 [TBL] [Abstract][Full Text] [Related]
6. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Kim MJ; Cardiff RD; Desai N; Banach-Petrosky WA; Parsons R; Shen MM; Abate-Shen C Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2884-9. PubMed ID: 11854455 [TBL] [Abstract][Full Text] [Related]
7. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Kim MJ; Bhatia-Gaur R; Banach-Petrosky WA; Desai N; Wang Y; Hayward SW; Cunha GR; Cardiff RD; Shen MM; Abate-Shen C Cancer Res; 2002 Jun; 62(11):2999-3004. PubMed ID: 12036903 [TBL] [Abstract][Full Text] [Related]
8. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Ouyang X; DeWeese TL; Nelson WG; Abate-Shen C Cancer Res; 2005 Aug; 65(15):6773-9. PubMed ID: 16061659 [TBL] [Abstract][Full Text] [Related]
9. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1. Abdulkadir SA Ann N Y Acad Sci; 2005 Nov; 1059():33-40. PubMed ID: 16382041 [TBL] [Abstract][Full Text] [Related]
11. Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein. Zhang X; Lee C; Ng PY; Rubin M; Shabsigh A; Buttyan R Prostate; 2000 Jun; 43(4):278-85. PubMed ID: 10861747 [TBL] [Abstract][Full Text] [Related]
12. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models. Linn DE; Bronson RT; Li Z PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911 [TBL] [Abstract][Full Text] [Related]
13. RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis. Logan M; Anderson PD; Saab ST; Hameed O; Abdulkadir SA Am J Pathol; 2013 Sep; 183(3):951-63. PubMed ID: 23867798 [TBL] [Abstract][Full Text] [Related]
14. Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis. Fonseca-Alves CE; Rodrigues MM; de Moura VM; Rogatto SR; Laufer-Amorim R Microsc Res Tech; 2013 Dec; 76(12):1250-6. PubMed ID: 24030851 [TBL] [Abstract][Full Text] [Related]
15. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer. Thangapazham R; Saenz F; Katta S; Mohamed AA; Tan SH; Petrovics G; Srivastava S; Dobi A BMC Cancer; 2014 Jan; 14():16. PubMed ID: 24418414 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of NKX3.1 and C-MYC expression in canine prostatic cancer. Fonseca-Alves CE; Kobayashi PE; Laufer-Amorim R Res Vet Sci; 2018 Jun; 118():365-370. PubMed ID: 29665565 [TBL] [Abstract][Full Text] [Related]
17. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity. Kim J; Roh M; Abdulkadir SA BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470 [TBL] [Abstract][Full Text] [Related]
18. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105 [TBL] [Abstract][Full Text] [Related]
20. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer. Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]